Case Study: Canadian Patient Receives Innovative Stem Cell Therapy for Type 2 Diabetes in Boao Lecheng

Date: April 21, 2026
Location: Boao Lecheng International Medical Tourism Pilot Zone, Hainan, China
Subject: 73-year-old Canadian Patient (Mr. Suppiah)
Treatment: Umbilical Cord Mesenchymal Stem Cell Therapy for Type 2 Diabetes

Overview

In a significant breakthrough for international medical tourism in China, the Boao Lecheng International Medical Tourism Pilot Zone has successfully completed a pioneering stem cell treatment for a Canadian citizen. This case highlights the growing global recognition of China's "Medical Special Zone" as a premier destination for regenerative medicine.

Patient Profile

Mr. Suppiah, a 73-year-old gentleman from Canada, had been suffering from Type 2 Diabetes for many years. Despite conventional treatments, his quality of life continued to decline, leading him to seek advanced therapeutic options at the Ciming Boao International Hospital in Hainan, China.

The Treatment: Precision and Innovation

The treatment was led by Professor Zhang Fan, a renowned expert and the Principal Investigator (PI) for the "Umbilical Cord Mesenchymal Stem Cell Therapy for Type 2 Diabetes" program at Ciming Boao.

Key Highlights of the Procedure:

1. Personalized Assessment: Professor Zhang’s team conducted a comprehensive medical evaluation to design a treatment plan tailored specifically to Mr. Suppiah’s condition.

2. Regulatory Approval: The therapy used is a standardized innovation officially approved by the Boao Lecheng Medical Products Administration in December 2025.

3. Seamless Execution: The procedure was reported as safe, scientific, and smooth, demonstrating the high operational standards of the pilot zone.

4. Extended Care: The service includes a one-year post-treatment disease management program, providing Mr. Suppiah with long-term medical follow-up despite being overseas.

Why Boao Lecheng?

This case marks a pivotal shift in the medical landscape. Historically, Chinese patients traveled abroad for advanced treatments. Now, international patients like Mr. Suppiah are traveling to China to access cutting-edge therapies that are "first-in-China" and often "first-in-the-world."

The Boao Lecheng International Medical Tourism Pilot Zone offers unique policy advantages:

• Special Medical Policy: Access to innovative drugs and devices not yet available elsewhere in the country.

• Real-World Data Application: Accelerating the approval and application of global medical innovations.

• Cost Efficiency: Leveraging the Hainan Free Trade Port’s "zero-tariff" policy for medical equipment.

A New Era of Medical Tourism

The successful treatment of Mr. Suppiah is a testament to the "Invite In" and "Go Global" strategy of the Hainan Free Trade Port. As the zone continues to deepen its clinical transformation of front-line medical technologies, it is setting a new benchmark for global health and regenerative medicine.

Conclusion

For international patients seeking a new lease on life through stem cell therapy, Boao Lecheng represents a beacon of hope. With world-class specialists like Professor Zhang Fan and a "Head-of-State" standard of service, the future of global healthcare is here, in Hainan.

For more information on stem cell treatments and how to start your journey to Boao Lecheng, contact our professional service team today.